Advertisement

Parasitic Diseases in the Compromised Host

  • Joel Ruskin
Chapter
  • 21 Downloads

Abstract

In the United States, Western Europe, and the mature health care delivery systems of Asia and Africa, two parasitic diseases should be carefully considered in the evaluation of fever and possible infection in the immunocompromised host: toxoplasmosis and pneumocystosis. In addition, three other diseases—strongyloidiasis, giardiasis, and babesiosis—occasionally occur in patients who are immunosuppressed or splenectomized. The ongoing epidemic of acquired immunodeficiency syndrome (AIDS) has called our attention to two coccidial protozoa—Cryptosporidium and Isospora belli—as causes of diarrhea. These entities should be suspected in any patient with compromised cell-mediated immunity and symptoms of gastroenteritis. It should, however, be acknowledged that in many of the developing countries of the world a number of other common parasitic entities can be expected to afflict both immunosuppressed and normal hosts. Thus, malaria and Chagas disease are occasional causes of transfusion-associated infection, and the risk of hematogenous trypanosomiasis is sufficiently great that in Brazil serologic screening for evidence of infection is analogous to the mandatory requirements for hepatitis serological testing in the United States.1

Keywords

Parasitic Disease Immunocompromised Host Open Lung Biopsy Tissue Cyst Hodgkin Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Weinstein RA, Young LS: Other procedure-related infections. In Bennett JV, Brachman PS (eds): Hospital Infections. Little, Brown, Boston, 1979, pp. 489–505.Google Scholar
  2. 2.
    Tapper ML, Armstrong D: Malaria complicating neoplastic disease. Arch Intern Med 136: 807–810, 1976.PubMedCrossRefGoogle Scholar
  3. 3.
    Ma DDF, Concannon AJ, Hayes J: Fatal leishmaniasis in renal-transplant patients. Lancet 2: 311–312, 1979.PubMedCrossRefGoogle Scholar
  4. 4.
    Smith JW, Bartlett MS: In Vitro cultivation of Pneumocystis. In LS Young (ed): Pneumocystis carinii Pneumonia. Dekker, New York, 1984, pp. 107–138.Google Scholar
  5. 5.
    Young LS (ed): Pneumocystis carinii Pneumonia. Dekker, New York, 1984.Google Scholar
  6. 5a.
    Ruskin J, Spotkov J: Pneumocystis infection. In Spittell JA, Jr (ed): Clinical Medicine, Vol. 3. Harper and Row, New York, 1986, pp. 1–18.Google Scholar
  7. 6.
    Dutz W: Pneumocystis carinii pneumonia. Pathol Annu 5: 309–341, 1970.Google Scholar
  8. 7.
    Van der Meer G, Brug SL: Infection par pneumocystis chez l’homme et chez les animaux. Ann Soc Belg Med Trop 22: 301–307, 1942.Google Scholar
  9. 8.
    Vanek J, Jirovec O: Parasitare penumonie. “Interstitielle” plasmazell pneumonie der frugeburten verursach durch Pneumocystis carinii. Zentralbi Bakteriol 158: 120–127, 1952.Google Scholar
  10. 9.
    Frenkel JK: Pneumocystis jiroveci n. sp. In Robbins JB, Devita VT Jr, Dutz W (eds): Symposium on Pneumocystis carinii Infection, NCI Monograph #43. National Cancer Institute, Washington, D.C., 1976, pp. 13–30.Google Scholar
  11. 10.
    Ivady G, Paldy L: Ein neues Behandlung sverfarhren der interstitiellen plasmazelligen Pneumonie fruhgeborener mit funtwertigen Stibium und aromatischen Diamidinen. Monatsschr Kinderheilkd 106: 10–14, 1958.PubMedGoogle Scholar
  12. 11.
    Gajdusek DC: Pneumocystis carinii-etiologic agent of interstitial plasma cell pneumonia of young and premature infants. Pediatrics 19: 543–545, 1957.Google Scholar
  13. 12.
    Frenkel JK, Good JT, Shultz JA: Latent pneumocystic infection of rats, relapse, and chemotherapy. Lab Invest 15: 1559–1577, 1966.PubMedGoogle Scholar
  14. 13.
    Hughes WT, McNabb PC, Makres, TD, et al: Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis. Antimicrob Agents Chemother 5: 289–293, 1974.PubMedCrossRefGoogle Scholar
  15. 14.
    Hughes WT, Feldman S, Sanyal SK: Treatment of Pneumocystis carinii pneumonitis with trimethoprim/sulfamethoxazole. Can Med Assoc J 112: 47S - 50S, 1975.Google Scholar
  16. 15.
    Lau WK, Young LS: Trimethoprim-sulfamethoxazole treatment of Pneumocystis carinii pneumonia in adults. N Engl J Med 295: 716–718, 1976.PubMedCrossRefGoogle Scholar
  17. 16.
    Hughes WT, Kuhn S, Chaudhary S, et al: Successful chemoprophylaxis of Pneumocystis carinii pneumonitis. N Engl J Med 297: 1419–1426, 1977.PubMedCrossRefGoogle Scholar
  18. 17.
    Winston DJ, Gale RP, Meyer DV, et al: Infectious complications of human bone marrow transplantation. Medicine (Baltimore) 58: 1–31, 1979.CrossRefGoogle Scholar
  19. 18.
    Murray JF, Felton CP, Garay SM, et al: Pulmonary complications of the acquired immunodeficiency syndrome: Report of a National Heart, Lung and Blood Institute workshop. N Engl J Med 310: 1682–1688, 1984.PubMedCrossRefGoogle Scholar
  20. 19.
    Zakowski PC, Gottlieb MS, Groopman J: Acquired immunodeficiency syndrome (AIDS), Kaposi’s sarcoma, and Pneumocystis carinii pneumonia. In LS Young (ed): Pneumocystis carinii pneumonia. Dekker, New York, 1984, pp. 195–226.Google Scholar
  21. 20.
    Hughes WT, Smith BL: Efficacy of diaminodiphenyl sulfone and other drugs in murine Pneumocystis carinii pneumonitis. Antimicrob Agents Chemother 26: 436–440, 1984.PubMedCrossRefGoogle Scholar
  22. 20a.
    Ruskin J: Newer developments in diagnosis and treatment of pneumocystis infections. In Remington JS, And Swartz MN (eds): Current Clinical Topics in Infectious Diseases, Vol. 7. McGraw-Hill, New York, 1986, pp. 194–215.Google Scholar
  23. 21.
    Smith JW, Bartlett MS: Diagnosis of pneumocystis pneumonia. Lab Med 10: 430–435, 1979.Google Scholar
  24. 22.
    Campbell WG: Ultrastructure of pneumocystis in human lung. Arch Pathol Lab Med 93: 312–324, 1972.Google Scholar
  25. 23.
    Vossen MEMH, Beckers PJA, Meuwissen JHETL, et al: Developmental biology of Pneumocystis carinii, an alternative view on the life cycle of the parasite. Z Parasitenkd 55: 101–118, 1978.PubMedCrossRefGoogle Scholar
  26. 24.
    Hughes WT, Price RA, Kim HK, et al: Pneumocystis carinii pneumonitis in children with malignancies. J Pediatr 82: 404–415, 1973.PubMedCrossRefGoogle Scholar
  27. 25.
    Awen C, Baltzan M: Systemic dissemination of Pneumocystis carinii pneumonia. Can Med Assoc J 104: 809–812, 1971.PubMedGoogle Scholar
  28. 25a.
    Coulman CU, Greene I, Archibald RWR: Cutaneous pneumocystis. Ann Intern Med 106: 396–398, 1987.PubMedGoogle Scholar
  29. 25b.
    Kwok S, O’Donnell JJ, Wood IS: Retinal cotton-wool spots in a patient with Pneumocystis carinii infection. N Engl J Med 307: 184–185, 1982.PubMedGoogle Scholar
  30. 26.
    Barnett RW, Hull JG, Vortel V, et al: Pneumocystis carinii in lymph nodes and spleen. Arch Pathol Lab Med 88: 175–181, 1969.Google Scholar
  31. 27.
    Brzosko WJ, Nowoslawski A: Identification of Pneumocystis carinii antigens in tissues. Bull Acad Pol Sci 13: 49–54, 1965.Google Scholar
  32. 28.
    Redman JC: Pneumocystis carinii pneumonia in an adopted Vietnamese infant. JAMA 230: 1561–1563, 1973.Google Scholar
  33. 29.
    Lyons, HA, Vinijchaikul K, Hennigar GR: Pneumocystis carinii pneumonia unassociated with other disease. Arch Intern Med 108: 173–180, 1961.CrossRefGoogle Scholar
  34. 30.
    Hughes WT, Price RA, Sisko F, et al: Protein calorie malnutrition: A host determinant for Pneumocystis carinii infection. Am J Dis Child 128: 44–50, 1974.PubMedGoogle Scholar
  35. 31.
    Walzer PD, Schnelle V, Armstrong D, et al: Nude mouse: A new experimental mode for Pneumocystis carinii infection. Science 197: 177–179, 1977.PubMedCrossRefGoogle Scholar
  36. 32.
    Walzer PD, Perl DP, Krogstad DJ, et al: Pneumocystis carinii pneumonia in the United States: Epidemiologic, diagnostic, and clinical features. Ann Intern Med 80: 83–93, 1974.PubMedGoogle Scholar
  37. 33.
    Masur H, Jones TC: The interaction in vitro of Pneumocystis carinii with macrophages and L-cells. J Exp Med 147: 157–170, 1978.PubMedCrossRefGoogle Scholar
  38. 34.
    Walzer PD, Schultz MG, Western KA: Pneumocystis carinii pneumonia and primary immune deficiency disease of infancy and childhood. J Pediatr 82: 416–422, 1973.PubMedCrossRefGoogle Scholar
  39. 35.
    Veda K, Goto Y, Yamazaki S, et al: Chronic fatal pneumocystosis in nude mice. Jpn JExp Med 47: 475–482, 1977.Google Scholar
  40. 36.
    Hendley JO, Weller TH: Activation and transmission in rats of infection with pneumocystis. Proc Soc Exp Biol Med 137: 1401–1404, 1971.PubMedGoogle Scholar
  41. 37.
    Brazinsky JH, Phillips JE: Pneumocystis pneumonia transmission between patients with lymphoma. JAMA 209: 1527, 1969.PubMedCrossRefGoogle Scholar
  42. 38.
    Watanabe JM, Chinchinian H, Weitz C, et al: Pneumocystis carinii pneumonia in a family. JAMA 193: 119–120, 1965.CrossRefGoogle Scholar
  43. 39.
    Perera DR, Western KA, Johnson HD, et al: Pneumocystis carinii pneumonia in a hospital for children. JAMA 214: 1074–1078, 1970.PubMedCrossRefGoogle Scholar
  44. 40.
    Singer C, Armstrong D, Rosen PP, et al: Pneumocystis carinii pneumonia: A cluster of eleven cases. Ann Intern Med 82: 772–777, 1975.PubMedGoogle Scholar
  45. 41.
    Ruebush TK II, Weinstein RA, Baehner RL, et al: An outbreak of pneumocystis pneumonia in children with acute lymphocytic leukemia. Am J Dis Child 132: 143–148, 1978.PubMedGoogle Scholar
  46. 42.
    Meuwissen JHET, Tauber I, Leeuwenberg ADEM, et al: Parasitologic and serologic observations of infection with pneumocystis in humans. J Infect Dis 136: 43–49, 1977.PubMedCrossRefGoogle Scholar
  47. 43.
    Stagno S, Pifer LL, Hughes WT, et al: Pneumocystis carinii pneumonitis in young, immunocopetent infants. Pediatrics 66: 56–62, 1980.PubMedGoogle Scholar
  48. 44.
    Western KA, Perera DR, Schultz MG: Pentamidine isethionate in the treatment of Pneumocystis carinii pneumonia. Ann Intern Med 73: 695–702, 1970.PubMedGoogle Scholar
  49. 45.
    Hughes WT, Sanyal SK, Price RA: Signs, symptoms and pathophysiology of Pneumocystis carinii pneumonitis. In Robbins JB, De Vita VT Jr, Dutz W (eds): Symposium on Pneumocystis carinii Infection. NCI Monograph #43. National Cancer Institute, Washington, DC, 1976, pp. 7788.Google Scholar
  50. 46.
    Walzer PD, Perl DP, Krogstad DJ, et al: Pneumocystis carinii pneumonia in the United States: Epidemiologic, diagnostic and clinical features. In Robbins JB, DeVita VT Jr, Dutz W (eds): Symposium on Pneumocystis Carinii Infection. NCI Monograph #43. National Cancer Institute, Washington, DC, 1976, pp. 55–63.Google Scholar
  51. 47.
    Wang NS, Huang SN, Thurlbeck WM: Combined Pneumocystis carinii and cytomegalovirus infection. Arch Pathol Lab Med 90: 529–535, 1970.Google Scholar
  52. 48.
    Hughes WT, Feldman S, Aur RJA, et al: Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis. Cancer 36: 2004–2009, 1975.PubMedCrossRefGoogle Scholar
  53. 49.
    Hughes WT, Feldman S, Chaudhary SC, et al: Comparison of pentamidine isethionate and trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. J Pediatr 92: 285–291, 1978.PubMedCrossRefGoogle Scholar
  54. 50.
    Turbiner EH, Yeh SDJ, Rosen PP, et al: Abnormal gallium scintigraphy in Pneumocystis carinii pneumonia with a normal chest radiography. Radiology 127: 437–438, 1978.PubMedGoogle Scholar
  55. 51.
    Levenson SM, Warren RD, Richman SD, et al: Abnormal pulmonary gallium accumulation in P. carinii pneumonia. Radiology 119: 395–398, 1976.PubMedGoogle Scholar
  56. 52.
    Sirotzky L, Memoli V, Roberts JL, et al: Recurrent pneumocystis pneumonia with normal chest roentgenograms. JAMA 240: 1513–1515, 1978.PubMedCrossRefGoogle Scholar
  57. 53.
    Doppman JL, Geelhoed GW: Atypical radiographic features in Pneumocystis carinii pneumonia. In Robbins JB, De Vita VT Jr, Dutz W (eds): Symposium on Pneumocystis carinii Infection. NCI Monograph #43. National Cancer Institute, Washington, DC, 1976, pp. 89–97.Google Scholar
  58. 54.
    Cross AS, Steigbigel RT: Pneumocystis carinii pneumonia presenting as localized nodular densities. N Engl J Med 291: 831–832, 1974.PubMedCrossRefGoogle Scholar
  59. 55.
    Luddy RE, Champion LAA, Schwartz AD: Pneumocystis carinii pneumonia with pneumatocoele formation. Am J Dis Child 131: 470–471, 1977.PubMedGoogle Scholar
  60. 56.
    Goodell B, Jacobs JB, Powell RD, et al Pneumocystis carinii: The spectrum of diffuse interstitial pneumonia in patients with neoplastic disease. Ann Intern Med 72:337–340, 1970.Google Scholar
  61. 57.
    Rossiter SJ, Miller DC, Churg AM, et al: Open lung biopsy in the immunosuppressed patient. J Thorac Cardiovasc Surg 77: 338–345, 1979.PubMedGoogle Scholar
  62. 58.
    Greenman RL, Goodall PT, King D: Lung biopsy in immunocompromised hosts. Am J Med 59: 488–496, 1975.PubMedCrossRefGoogle Scholar
  63. 59.
    Pennington JE, Feldman NT: Pulmonary infiltrates and fever in patients with hematologic malignancy: Assessment of transbronchial biopsy. Am J Med 62: 581–587, 1977.PubMedCrossRefGoogle Scholar
  64. 60.
    Fishman NH: Discussion. J Thorac Cardiovasc Surg 77: 344, 1979.Google Scholar
  65. 61.
    Springmeyer SC, Silvestri RC, Sale GE, et al: Role of trans-bronchial biopsy for the diagnosis of diffuse pneumonia in immunocompromised marrow transplant recipients. Am Rev Respir Dis 126: 763–765, 1982.PubMedGoogle Scholar
  66. 62.
    Burt ME, Flye WW, Webber BL, Wesley RA: Prospective evaluation of aspiration needle, cutting needle, trans-bronchial, and open lung biopsy in patients with pulmonary infiltrates. Ann Thorac Surg 32: 146–153, 1981.PubMedCrossRefGoogle Scholar
  67. 63.
    Bigby PD, Margolskee D, Curtis J, et al: Usefulness of induced sputum in diagnosis of pneumonia in patients with Acquired Immunodeficiency Syndrome. Am Rev Respir Dis 133: 515–518, 1986.PubMedGoogle Scholar
  68. 64.
    Lau WK, Young LS, Remington JS: Pneumocystis carinii pneumonia. Diagnosis by examination of pulmonary secretions. JAMA 236: 2399–2402, 1976.PubMedCrossRefGoogle Scholar
  69. 65.
    Lorber B, Swenson RM: Bacteriology of aspiration pneumonia: A prospective study of community and hospital acquired cases. Ann Intern Med 81: 329–331, 1974.PubMedGoogle Scholar
  70. 66.
    Chaudhary S, Hughes WT, Feldman S, et al: Percutaneous transthoracic needle aspiration of the lung. Am J Dis Child 131: 902–907, 1977.PubMedGoogle Scholar
  71. 67.
    Stover DE, Zaman ME, Hadju SI, Lange M, et al: Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunocompromised host. Ann Intern Med 101: 1–6, 1984.PubMedGoogle Scholar
  72. 68.
    Lim SK, Eveland WC, Porter RI: Direct fluorescent-antibody method for the diagnosis of Pneumocystis carinii pneumonitis from sputa or tracheal aspirates from humans. Appl Microbiol 27: 144–149, 1974.PubMedGoogle Scholar
  73. 69.
    Kovacs JA, Gill V, Swan JC, et al: Prospective evaluations of a monoclonal antibody in diagnosis of Pneumocystis carinii pneumonia. Lancet 2: 1–3, 1986.PubMedCrossRefGoogle Scholar
  74. 70.
    Meuwissen JHET, Leeuwenberg ADEM: A microcomplement fixation test applied to infection with Pneumocystis carinii. Trop Georgr Med 24: 282–291, 1972.Google Scholar
  75. 71.
    Norman L, Kagan IG: Some observations on the serology of Pneumocystis carinii infections in the United States. Infect Immunol 8: 317–321, 1973.Google Scholar
  76. 72.
    Meyer JD, Pifer LL, Sale GE, et al: The value of Pneumocystis carinii antibody and antigen detection for diagnosis of Pneumocystis carinii pneumonia after marrow transplantation. Am Rev Respir Dis 120: 181–182, 1979.Google Scholar
  77. 73.
    Pifer LL: Serodiagnosis of Pneumocystis carinii. Chest 87: 698–700, 1985.Google Scholar
  78. 74.
    Hughes WT: Recent advances in serodiagnosis of Pneumocystis carinii. Chest 89: 764–765, 1986.Google Scholar
  79. 75.
    Waalkes TP, Makulu DR: Pharmacologic aspects of pen tamidine. In Robbins JB, DeVita VT Jr, Dutz W (eds): Symposium on Pneumocystis carinii Infection. NCI Monograph #43. National Cancer Institute, Washington, DC, 1976, pp. 171–177.Google Scholar
  80. 76.
    Young RC, DeVita VT Jr: Treatment of Pneumocystis carinii pneumonia. In Robbins JB, DeVita VT Jr, Dutz W (Eds): Symposium on Pneumocystis carinii Infection. NCI Monograph #43. National Cancer Institute, Washington, DC, 1976, pp. 193–198.Google Scholar
  81. 77.
    Dutz W, Post C, Jennings-Khodadad E, et al: Therapy and prophylaxis of Pneumocystis carinii. In Robbins JB, Devita VT Jr, Dutz W (eds): Symposium on Pneumocystis carinii Infection. NCI Monograph # 43. National Cancer Institute, Washington, DC, 1976, pp. 179–185.Google Scholar
  82. 78.
    Kluge RM, Spaulding DM, Spain JA: Combination of pentamidine and trimethoprim-sulfamethoxazole in the therapy of Pneumocystis carinii pneumonia in rats. Antimicrob Agents Chemother 13: 975–978, 1978.PubMedCrossRefGoogle Scholar
  83. 79.
    Whisnant JK, Buckley RH: Successful pyrimethamine-sulfadiazine therapy of pneumocystis pneumonia in infants with X-linked immunodeficiency with hyper IgM. In Robbins JB, DeVita VT Jr, Dutz W (eds): Symposium on Pneumocystis carinii Infection. NCI Monograph #43. National Cancer Institute, Washington, DC, 1976, pp. 211–216.Google Scholar
  84. 80.
    Post C, Fakoughi T, Dutz W, et al: Prophylaxis of epidemic infantile pneumocystosis with a 20: 1 sulfadoxine and pyrimethamine combination. Curr Ther Res 13: 273–279, 1971.PubMedGoogle Scholar
  85. 81.
    Winston DJ, Lau WK, Gale RP, et al: Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia. Ann Intern Med 92: 762–769, 1980.PubMedGoogle Scholar
  86. 82.
    Young LS: Treatment of Pneumocystis carinii pneumonia in adults with trimethoprim/sulfamethoxazole. Rev Infect Dis 4: 608–613, 1982.PubMedCrossRefGoogle Scholar
  87. 83.
    Haverkos HW: PCP Therapy Project Group. Assessment of therapy for Pneumocystis carinii pneumonia. Am J Med 76: 501–508, 1984.PubMedCrossRefGoogle Scholar
  88. 84.
    Kovacs JA, Hiemenz JM, Macher AM, et al: Pneumocystis carinii pneumonia: A comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 100: 495–499, 1984.Google Scholar
  89. 85.
    Wharton JM, Coleman DL, Wofsy CB, et al: Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med 105: 37–44, 1986.PubMedGoogle Scholar
  90. 86.
    Bernard EM, Donnelly JH, Maher MP, et al: Use of a new bioassay to study pentamidine pharmacokinetics. J Infect Dis 152: 750–754, 1985.PubMedCrossRefGoogle Scholar
  91. 87.
    Leoung GS, Mills J, Hopewell PC, et al: Dapsone-Trimethoprim for Pneumocystis carinii in the acquired immunodeficiency syndrome. Ann Intern Med 105: 45–48, 1986.PubMedGoogle Scholar
  92. 88.
    Allegra CJ, Kovacs JA, Chabner BA, et al: Potent in vivo and in vitro activity of a lipid soluble antifolate, trimetrexate against Pneumocystis carinii. Clin Res 34: 674A, 1986.Google Scholar
  93. 89.
    Golden JA, Sjoerdsma A, Santi DV: Pneumocystis carinii pneumonia treated with alpha-difluoromethylornithine. West J Med 141: 613–623, 1984.PubMedGoogle Scholar
  94. 90.
    Hughes WT, Smith-McCain BL: Effects of sulfonyl urea compounds on Pneumocystis carinii. J Infect Dis 153: 944–947, 1986.PubMedCrossRefGoogle Scholar
  95. 90a.
    Hughes WT, Rivera GK, Schell MJ, et al: Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 316: 1627–1632, 1987.PubMedCrossRefGoogle Scholar
  96. 91.
    Hughes WT: Limited effect of trimethoprim sulfamethoxazole prophylaxis on Pneumocystis carinii. Antimicrob Agents Chemother 16: 333–335, 1979.CrossRefGoogle Scholar
  97. 92.
    Hughes WT, Johnson WW: Recurrent Pneumocystis carinii pneumonia following apparent recovery. J Pediatr 79: 755–759, 1971.PubMedCrossRefGoogle Scholar
  98. 93.
    Gottlieb M, Knight S, Mitsuyasu R, et al: Prophylaxis of Pneumocystis carinii infection in acquired immunodeficiency syndrome (AIDS) with pyrimethamine/sulfadoxine (Fansidar). Lancet 2: 398–399, 1984.PubMedCrossRefGoogle Scholar
  99. 94.
    Dammin GJ: Babesiosis. In Weinstein L, Fields BN (eds): Seminars in Infectious Diseases. Vol 1. Stratton International, New York, 1978, pp. 169–199.Google Scholar
  100. 95.
    Healy GR: Babesia infections in man. Hosp Prac 13: 107116, 1979.Google Scholar
  101. 96.
    Ruebush TK II, Spielman A: Human babesiosis in the United States. Ann Intern Med 88: 263, 1978.PubMedGoogle Scholar
  102. 97.
    Ruebush TK II, Cassaday PB, March HJ, et al: Human babesiosis on Nantucket Island: Clinical features. Ann Intern Med 86: 6–9, 1977.Google Scholar
  103. 98.
    Ruebush TK II, Juranek DD, Chisholm ES, et al: Human babesiosis on Nantucket Island: Evidence for self-limited and subclinical infections. N Engl J Med 297: 825–827, 1977.PubMedCrossRefGoogle Scholar
  104. 99.
    Entrican JH, Williams H, Cook IA, et al: Babesiosis in man: A case from Scotland. Br Med J 2: 474, 1979.PubMedCrossRefGoogle Scholar
  105. 100.
    Healy GR, Walzer PD, Sulzer AI: A case of asymptomatic babesiosis in Georgia. Am J Trop Med Hyg 25: 376–378, 1976.PubMedGoogle Scholar
  106. 101.
    Chisholm ES, Ruebush TK II, Sulzer Ai, et al: Babesia microti infection in man: Evaluation of an indirect immunofluorescent antibody test. Am J Trop Med Hyg 7: 14–19, 1978.Google Scholar
  107. 102.
    Miller LH, Neva FH, Gill F: Failure of chloroquine in human babesiosis (Babesia microti). Ann Intern Med 88: 200–202, 1978.PubMedGoogle Scholar
  108. 103.
    Rowin KS, Tanowitz HB, Wittner M: Therapy of experimental babesiosis. Ann Intern Med 97: 556–558, 1982.PubMedGoogle Scholar
  109. 104.
    Stevens, DP, Mahmoud AAF: Giardiasis: The rediscovery of an ancient pathogen. In Remington JS, Swartz MN (eds): Current Clinical Topics in Infectious Disease, McGraw-Hill, New York, 1980, pp. 195–207.Google Scholar
  110. 105.
    Brodsky RE, Spencer HC, Schultz MG: Giardiasis in American travelers in the Soviet Union. J Infect Dis 130: 319–323, 1974.PubMedCrossRefGoogle Scholar
  111. 106.
    Butler T, Middleton FG, Earnest DL, et al: Chronic and recurrent diarrhea in American servicemen in Vietnam. Arch Intern Med 132: 373–377, 1973.PubMedCrossRefGoogle Scholar
  112. 107.
    Shaw PK, Brodsky RE, Lyman DO, et al: A community-wide outbreak of giardiasis with documented transmission by municipal water. Ann Intern Med 87: 426–432, 1977.PubMedGoogle Scholar
  113. 108.
    Horwitz MA, Hughes JM, Craun GF: Outbreaks of waterborne disease in the United States, 1974. J Infect Dis 133: 588–593, 1976.PubMedCrossRefGoogle Scholar
  114. 109.
    Dykes AC, Juranek DD, Lorenz RA: Municipal water-borne giardiasis: An epidemiologic investigation: Beavers implied as a possible reservoir. Ann Intern Med 92 (part I): 165–170, 1980.PubMedGoogle Scholar
  115. 110.
    Hermans PE, Huizenga KA, Hoffman HN, et al: Dysgammaglobulinemia associated with nodular lymphoid hyperplasia of the small intestine. Am J Med 40: 78–89, 1966.PubMedCrossRefGoogle Scholar
  116. 111.
    Ament ME, Ochs HD, Davis SD: Structure and function of the gastrointestinal tract in primary immunodeficiency syndrome: A study of 39 patients. Medicine (Baltimore) 52: 227–248, 1973.CrossRefGoogle Scholar
  117. 112.
    Barbour AG, Nichols CR, Fukushima T: An outbreak of giardiasis in a group of campers. Am J Trop Med 25: 384–389, 1976.Google Scholar
  118. 113.
    Black RE, Dykes AC, Sinclair SP, et al: Giardiasis in daycare centers: Evidence of person-to-person transmission. Pediatrics 60: 486–491, 1977.PubMedGoogle Scholar
  119. 114.
    Schmerin MJ, Jones TC, Klein H, et al: Giardiasis: Association with homosexuality. Ann Intern Med 88: 801–803, 1978.PubMedGoogle Scholar
  120. 115.
    Keysteon JS, Krajden S, Warren MR: Person-to-person transmission of Giardia lamblia in day care nurseries. Can Med Assoc J 119: 241–248, 1978.Google Scholar
  121. 116.
    Roberts-Thomson IC, Stevens DP, et al: Acquired resistance to infection in an animal model of giardiasis. J Immunol 117: 2036–2037, 1976.PubMedGoogle Scholar
  122. 117.
    Rendtorff RC: The experimental transmission of human intestinal protozoan parasites: Giardia lamblia cysts given in capsules. Am J Hyg 59: 209–220, 1954.PubMedGoogle Scholar
  123. 118.
    Saha TK, Ghosh TK: Invasion of small intestinal mucosa by Giardia lamblia in man. Gastroenterology 72: 402–405, 1977.PubMedGoogle Scholar
  124. 119.
    Hoskins LC, Winawer SJ, Broitman SA, et al: Clinical giardiasis and intestinal malabsorption. Gastroenterology 53: 265–279, 1967.Google Scholar
  125. 120.
    Morecki R, Parker JG: Ultrastructural studies of the human Giardia lamblia and subjacent jejunal mucosa in a subject with steatorrhea. Gastroenterology 52: 51–164, 1967.Google Scholar
  126. 121.
    Ament ME, Rubin CE: Relation of giardiasis to abnormal intestinal structure and function in gastrointestinal immunodeficiency syndromes. Gastroenterology 62: 216–226, 1972.PubMedGoogle Scholar
  127. 122.
    Erlandsen SL, Chase DG: Morphological alterations in the microvillous border of villous epithelial cells produced by intestinal microorganisms. Am J Clin Nutr 27: 1277–1286, 1974.PubMedGoogle Scholar
  128. 123.
    Sheehy TW, Holley HP Jr: Giardia-induced malabsorption in pancreatitis. JAMA 233: 1373–1375, 1975.PubMedCrossRefGoogle Scholar
  129. 124.
    Tandon BN, Tandon RK, Satpathy BK, et al: Mechanism of malabsorption in giardiasis: A study of bacterial flora and bile salt deconjugation in upper jejunum. Gut 18: 176–181, 1977.PubMedCrossRefGoogle Scholar
  130. 125.
    Stevens DP, Frank DM, Mahmoud AAF: Thymus dependency of host resistance to Giardia muris infection: Studies in nude mice. J Immunol 120: 680–682, 1978.PubMedGoogle Scholar
  131. 126.
    Roberts-Thomson IC, Mitchell GF: Giardiasis in mice. I. Prolonged infections in certain mouse strains and hypothymic (nude mice). Gastroenterology 75: 42–50, 1978.PubMedGoogle Scholar
  132. 127.
    Stevens DP, Frank DM: Local immunity in murine giardiasis. Is milk protective at the expense of material gut? Trans Assoc Am Physicians 91: 268–272, 1978.PubMedGoogle Scholar
  133. 128.
    Zinneman HH, Kaplan AP: The association of giardiasis with reduced intestinal secretory immunoglobulin A. Am J Dig Dis 17: 793–797, 1972.PubMedCrossRefGoogle Scholar
  134. 129.
    Jones EG, Brown WR: Serum and intestinal fluid immunoglobulin in patients with giardiasis, Am JDig Dis 19: 791–796, 1974.CrossRefGoogle Scholar
  135. 130.
    Bezjak B: Evaluation of a new technique for sampling duodenal contents in parasitologic diagnosis. Am J Dig Dis 17: 848–850, 1972.PubMedCrossRefGoogle Scholar
  136. 131.
    Roe FJ: Metronidazole: Review of uses and toxicity. J Antimicrob Chemother 3: 205–212, 1977.PubMedCrossRefGoogle Scholar
  137. 132.
    Knight R, Wright SG: Progress report. Intestinal protozoa. Gut 19: 940, 1978.PubMedCrossRefGoogle Scholar
  138. 133.
    Rustia M, Shubik P: Induction of lung tumors and malignant lymphomas in mice by metronidazole, J Nall Cancer Inst 48: 721–726, 1972.Google Scholar
  139. 134.
    Voogd CE, Van der Steel JJ, Jacobs JA: The mutagenic action of nitroimidazoles: I. Metronidazole, dimetridazole and ronidazole. Mutation Res 26: 483–490, 1974.PubMedCrossRefGoogle Scholar
  140. 135.
    Beard CM, Noller KL, O’Fallon WM, et al: Lack of evidence for cancer due to use of metronidazole. N Engl J Med 301: 519, 1979.PubMedCrossRefGoogle Scholar
  141. 136.
    Luft BI, Brooks RG, Conley FK, et al: Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. JAMA 252: 913–917, 1984.PubMedCrossRefGoogle Scholar
  142. Wong B, Gold JWM. Brown AE, et al: Central-nervoussystem toxoplasmosis in homosexual men and parenteral drug abusers. Ann Intern Med 100:36–42, 1984.Google Scholar
  143. 138.
    Feldman HA: Toxoplasmosis. N Engl J Med 279: 1431–1437, 1968.PubMedCrossRefGoogle Scholar
  144. 139.
    Remington JS: Toxoplasmosis in the adult. Bull NY Acad Med 50: 211–227, 1974.Google Scholar
  145. 140.
    Feldman HA; Toxoplasmosis: An overview. Bull NY Acad Med 50: 110–127, 1974.Google Scholar
  146. 141.
    Janku J: Pathogenesis and pathologic anatomy of coloboma of macula lutea in eye of normal dimensions, and in micro-ophthalmic eye with parasites in return. Cas Lek Clsk 62: 1021–1027, 1923.Google Scholar
  147. 142.
    Wolf A, Cowen D, Paige B: Human toxoplasmosis: Occurrence in infants as an encephalomyelitis. Verification by transmission to animals. Science 89: 226–227, 1939.PubMedCrossRefGoogle Scholar
  148. 143.
    Sabin AV, Ruchman I: Characteristics of toxoplasma neutralizing antibody. Proc Soc Exp Biol Med 51: 1–6, 1942.Google Scholar
  149. 144.
    Sabin A, Feldman HA: Dyes as michrochemical indicators of a new immunity phenomenon affecting a protozoan parasite (Toxoplasma). Science 108: 660–663, 1978.CrossRefGoogle Scholar
  150. 145.
    Siim IC: Acquired toxoplasmosis: Report of seven cases with strongly positive serologic reactions. JAMA 147: 1651–1645, 1951.CrossRefGoogle Scholar
  151. 146.
    Gard S, Magnusson JH: Glandular form of toxoplasmosis in connection with pregnancy. Acta Med Scand 141: 59–64, 1951.PubMedCrossRefGoogle Scholar
  152. 147.
    World Health Organization: Toxoplasmosis. Technical Report Series 431. The World Health Organization, Geneva, 1969.Google Scholar
  153. 148.
    Anderson SE Jr, Remington IS: Toxoplasmosis. In Hoeprich PD (ed): Infectious Diseases. Harper & Row, Hagerstown, Maryland, 1977, pp. 967–976.Google Scholar
  154. 149.
    McLeod R, Remington JS: Influence of infection with toxoplasma on macrophage function, and role of macrophages in resistance to toxoplasma. Am J Trop Med Hyg 26: 170–186, 1977.PubMedGoogle Scholar
  155. 150.
    Lindberg RE, Frenkel JK: Toxoplasmosis in nude mice. J Parasitol 63: 210–221, 1977.CrossRefGoogle Scholar
  156. 151.
    Frenkel JK: Effects of cortisone, total body radiation and nitrogen mustard on chronic latent toxoplasmosis. Am J Pathol 33: 618–619, 1957.Google Scholar
  157. 152.
    Strannegard O, Lycke E: Effect of antithymocyte serum on experimental toxoplasmosis in mice. Infect Immun 5: 769774, 1972.Google Scholar
  158. 153.
    Remington JS, Krahenbuhl IL, Mendenhall JW: A role for activated macrophages in resistance to infection with toxoplasma. Infect Immun 6: 829–834, 1972.PubMedGoogle Scholar
  159. 154.
    Jones TC, Len L, Hirsch J: Assessment in vitro of immunity against toxoplasma gondii. J Exp Med 171: 466–482, 1975.CrossRefGoogle Scholar
  160. 155.
    Anderson SE Jr, Remington JS: Effect of normal and activated human macrophages on Toxoplasma gondii. J Exp Med 139: 1154–1174, 1974.CrossRefGoogle Scholar
  161. 156.
    Murray HW, Gellene RA, Libby DM: Activation of tissue macrophages from AIDS patients: In vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma. J lmmunol 135: 2374–2377, 1985.Google Scholar
  162. 157.
    Nathan CF, Pendergast, Weiber ME, et al: Activation of human macrophages. Comparison of other cytokines with gamma interferon macrophages. J Exp Med 160: 600–609, 1984.PubMedCrossRefGoogle Scholar
  163. 158.
    Catteral JR, Sharma SD, Remington JS: Oxygen independent killing by alveolar macrophages. J Exp Med 163: 1113–1120, 1986.CrossRefGoogle Scholar
  164. 159.
    Swartzberg JE, Krahenbuhl, JL, Remington JS: Dichotomy between macrophage activation and degree of protection against Listeria monocytogenes and Toxoplasma gondii in mice stimulated with Corynebacterium parvum. Infect Immun 12: 1037–1043, 1975.Google Scholar
  165. 160.
    Leak D, Meghji M: Toxoplasmic infection in cardiac disease. Am J Cardiol 43: 841–849, 1979.PubMedCrossRefGoogle Scholar
  166. 161.
    Dorfman R, Remington J: Value of lymph-node biopsy in the diagnosis of acute acquired toxoplasmosis. N Engl J Med 289: 878–881, 1973.PubMedCrossRefGoogle Scholar
  167. 162.
    Ruskin J, Remington JS: Toxoplasmosis in the compromised host. Ann Intern Med 84: 193–199, 1976.PubMedGoogle Scholar
  168. 163.
    Ryning FW, McLeod R, Maddox JC, et al: Probable transmission of Toxoplasma gondii by organ transplantation. Ann Intern Med 90: 47–49, 1979.PubMedGoogle Scholar
  169. 164.
    Ghatak NR, Sawyer DR: A morphologic study of opportunistic cerebral toxoplasmosis. Acta Neuropathol 42: 217–221, 1978.PubMedCrossRefGoogle Scholar
  170. 165.
    Powell HC, Gibbs CI Jr, Lorenzo AM, et al: Toxoplasmosis of the central nervous system in the adult: Electron microscopic observations. Acta Neuropathol 41: 211–216, 1978.PubMedCrossRefGoogle Scholar
  171. 166.
    McLeod R, Berry PF, Marshall WH, et al: Toxoplasmosis presenting as brain abscess. Am J Med 67: 711–714, 1979.PubMedCrossRefGoogle Scholar
  172. 167.
    Frenkel JK, Amare M, Larsen W: Immune competence in a patient with Hodgkin’s disease and relapsing toxoplasmosis. Infection 6: 84–91, 1978.PubMedCrossRefGoogle Scholar
  173. 168.
    Slavick HE, Lipman IJ: Brain stem toxoplasmosis complicating Hodgkin’s diesase. Arch Neurol 34: 636–637, 1977.PubMedCrossRefGoogle Scholar
  174. 169.
    Whiteside JD, Begent RHJ: Toxoplasma encephalitis complicating Hodgkin’s disease. J Clin Pathol 28: 443–445, 1975.PubMedCrossRefGoogle Scholar
  175. 170.
    Nicholdon DH, Wolchok EB: Ocular toxoplasmosis in an adult receiving long-term corticosteroid therapy. Arch Ophthalmol 94: 248–257, 1976.CrossRefGoogle Scholar
  176. 171.
    Kersting F, Newmann J: “Malignant Lymphoma” of the brain following renal transplantation. Acta Neuropathol 6 (suppl VI): 131–133, 1975.Google Scholar
  177. 172.
    Herb HM, Jontofsoh R, Loftier HD, et al: Toxoplasmosis after renal transplantation. Clin Nephrol 8: 529–532, 1978.Google Scholar
  178. 173.
    Schulkof LA, Russell JR: Intracerebral toxoplasmosis presenting as a mass lesion. Surg Neurol 4: 9–11, 1975.Google Scholar
  179. 174.
    Barlotta FM, Odhoa M Jr, Neu HC, et al: Toxoplasmosis, lymphoma or both? Ann Intern Med 70: 517–528, 1979.Google Scholar
  180. 175.
    Menges HW, Fischer E, Valavanis A, et al: Cerebral toxoplasmosis in the adult. J Comput Assist Tomogr 3: 413–416, 1979.PubMedCrossRefGoogle Scholar
  181. 176.
    Shepp DH, Hackman RC, Conley FK, et al: Toxoplasma gondii reactivation identified by detection of parasitemia in tissue culture. Ann Intern Med 103: 218–221, 1985.PubMedGoogle Scholar
  182. 177.
    Jehn V, Fink M, Gundlach P: Lethal cardiac and cerebral toxoplasmosis in a patient with acute myeloid leukemia after successful allogenic bone marrow transplantation. Transplantation 38: 430–433, 1984.PubMedCrossRefGoogle Scholar
  183. 178.
    Hirsch R, Burke BA, Kersey JH: Toxoplasmosis in bone marrow transplant recipients. JPediatr 105: 426–428, 1984.CrossRefGoogle Scholar
  184. 179.
    Siegel S, Lunde M, Gelderman A, et al: Transmission of toxoplasmosis by leukocyte transfusion. Blood 37: 388–394, 1971.PubMedGoogle Scholar
  185. 180.
    Raisanen S: Toxoplasmosis transmitted by blood transfusions. Transfusion 18: 329–332, 1978.PubMedCrossRefGoogle Scholar
  186. 181.
    Rose AG, Uys CJ, Novitsky D, et al: Toxoplasmosis of donor and recipient hearts after heterotopic cardiac transplantations. Arch Pathol Lab Med 107: 368–373, 1983.PubMedGoogle Scholar
  187. 182.
    Snider WD, Simpson DM, Nielsen S, et al: Neurological complications of acquired immunodeficiency syndrome. Analysis of 50 patients. Ann Neurol 14: 403–418, 1983.PubMedCrossRefGoogle Scholar
  188. 183.
    Moskowitz LB, Kory P, Chan JC. et al: Unusual causes of death in Haitians residing in Miami. High prevalence of opportunistic infections. JAMA 250: 1187–1191, 1983.PubMedCrossRefGoogle Scholar
  189. 184.
    Hofflin JM, Remington IS: Tissue culture isolation of toxoplasma from blood of a patient with AIDS. Arch Intern Med 145: 925–926, 1985.PubMedCrossRefGoogle Scholar
  190. 185.
    Luft BJ, Remington JS: Toxoplasmosis of the central nervous system. In Remington JS, Swartz M (eds): Current Clinical Topics in Infectious Disease. Vol 5. McGraw-Hill, New York, 1985, pp. 315–358.Google Scholar
  191. 186.
    McCabe RE, Gibbons D, Brooks RG, et al: Agglutination test for diagnosis of toxoplasmosis in AIDS. Lancet 2: 680, 1983.PubMedCrossRefGoogle Scholar
  192. 187.
    Cooney MK, Kimball AC, Bauer H: Studies on toxoplasmosis. I. Complement fixation tests with peritoneal exudate antigen. J lmmunol 81: 177–186, 1958.Google Scholar
  193. 188.
    Walls KW, Bullock SL, English DK: Use of the enzyme-linked immunosorbent assay (ELISA) and its microadaptation for the serodiagnosis of toxoplasmosis, J Clin Microbiol 5: 273–277, 1977.PubMedGoogle Scholar
  194. 189.
    Siegel JP, Remington JS: Comparison of methods for quantitating antigen specific immunoglobulin M antibody with a reverse enzyme linked immunoabsorbent assay. J Clin Microbiol 18: 63–70, 1983.PubMedGoogle Scholar
  195. 190.
    Wielaard F, van Gruighuigsen H, Duermeyer W, et al: Diagnosis of acute toxoplasmosis by an enzyme immunoassay for specific immunoglobulin M antibodies. J Clin Microbiol 17: 981–987, 1983.PubMedGoogle Scholar
  196. 191.
    Gordon MA, Duncan RA, Kingsley LC: Automated immunofluorescence test for toxoplasmosis. J Clin Microb 13: 283–285, 1981.Google Scholar
  197. 192.
    Jacobs L, Lunde MN: A hemagglutination test for toxoplasmosis. J Parasitol 43: 308–314, 1957.PubMedCrossRefGoogle Scholar
  198. 193.
    Remington JS, Miller MJ, Brownlee I: IgM antibodies in acute toxoplasmosis. II. Prevalence and significance in acquired cases. J Lab Clin Med 71: 855–866, 1968.PubMedGoogle Scholar
  199. 194.
    Welch PC, Masur H, Jones TC, et al: Serologic diagnosis of acute lymphadenopathic toxoplasmosis. J Infect Dis 142: 256–264, 1980.PubMedCrossRefGoogle Scholar
  200. 195.
    Hakes TB, Armstrong D: Toxoplasmosis: Problems in diagnosis and treatment. Cancer 52: 1535–1540, 1983.PubMedCrossRefGoogle Scholar
  201. 196.
    Araujo FG, Remington JS: Antigenemia in recently acquired acute toxoplasmosis. J Infect Dis 141: 144–150, 1980.PubMedCrossRefGoogle Scholar
  202. 197.
    Brooks RG, Sharma SD, Remington JS: Detection of Toxoplasma gondii antigens by a dot-immunobinding technique. J Clin Microbiol 21: 113–116, 1985.PubMedGoogle Scholar
  203. 198.
    Rollins DF, Tabbara KF, O’Conner GR, et al: Detection of toxoplasma antigen and antibody in ocular fluids in experimental ocular toxoplasmosis. Arch Ophthalmol 101: 455–457, 1983.PubMedCrossRefGoogle Scholar
  204. 199.
    Wilson CB, Desmonts G, Couvreur J, et al: Lymphocyte transformation in the diagnosis of congenital toxoplasma infection. N Engl J Med 302: 785–788, 1980.PubMedCrossRefGoogle Scholar
  205. 200.
    Desmonts G: Definitive serologic diagnosis of ocular toxoplasmosis. Arch Ophthalmol 76: 839–851, 1966.PubMedCrossRefGoogle Scholar
  206. 201.
    Grossman P, Remington J: The effect of trimethoprim and sulfamethoxazole on toxoplasma gondii in vitro and in vivo. Am J Trop Med Hyg 28: 445–455, 1979.PubMedGoogle Scholar
  207. 202.
    O’Connor GR, Frenkel JK: Dangers of steroid treatment in toxoplasmosis. Arch Ophthalmol 94: 213, 1976.PubMedCrossRefGoogle Scholar
  208. 203.
    Ma P, Soave R: Three-step stool examination for crytosporidiosis in 10 homosexual men and protracted watery diarrhea. J Infect Dis 147: 824–828, 1983.PubMedCrossRefGoogle Scholar
  209. 204.
    Meisel IL, Perera DR, MeLigro C, et al: Overwhelming watery diarrhea associated with a cryptosporidium in an immunosuppressed patient. Gastroenterology 70: 1156–1160, 1976.PubMedGoogle Scholar
  210. 205.
    Weinstein L, Edelstein SM, Madara J, et al: Intestinal cryptosporidiosis complicated by disseminated cytomegalovirus infection. J Am Gastroenterol Assoc 81: 584–591, 1981.Google Scholar
  211. 206.
    Tzipori S: Cryptosporidiosis in animals and humans. Microbiol Rev 47: 84–96, 1983.PubMedGoogle Scholar
  212. 207.
    Weisburger WR, Hutcheon DF, Yardley JH, et al: Cryptosporidiosis in an immunosuppressed renal-transplant recipient with IgA deficiency. Am J Clin Pathol 72: 473–478, 1979.PubMedGoogle Scholar
  213. 208.
    Wolfson JS, Richter JM, Waldron MA, et al: Cryptosporidiosis in immunocompetent patients. N Engl J Med 213: 1278–1282, 1985.CrossRefGoogle Scholar
  214. 209.
    DuPont HL: Cryptosporidiosis and the healthy host. N Engl J Med 312: 1319–1320, 1985.PubMedCrossRefGoogle Scholar
  215. 210.
    Bogaerts J, Lepage P, Rouvroy D, et al: Cryptosporisium spp., a frequent cause of diarrhea in central Africa. J Clin Microb 20: 874–876, 1984.Google Scholar
  216. 211.
    Soave R, Ma P: Cryptosporidiosis—Traveler’s diarrhea in two families. Arch Intern Med 145: 70–72, 1985.PubMedCrossRefGoogle Scholar
  217. Current WL, Reese NC. Ernst JV, et al: Human cryptosporidiosis in immunocompetent and immunodeficient persons: Studies of an outbreak and experimental transmission. N Engl J Med 308:1252–1257, 1983.Google Scholar
  218. 213.
    Ma P, Villanueva TG, Kaufman D, et al: Respiratory cryptosporidiosis in the acquired immune deficiency syndrome: Use of modified cold Kinyoun and Hemacolor stains for rapid diagnoses. JAMA 252: 1298–1301, 1984.PubMedCrossRefGoogle Scholar
  219. 214.
    Portnoy D, Whiteside ME, Buckely III E, et al: Treatment of intestinal cryptosporidiosis with spiramycin. Ann Intern Med 101: 202–204, 1984.PubMedGoogle Scholar
  220. 215.
    DeHovitz JA, Pape, JW, Boncy M, et al: Clinical manifestations and therapy of Isospora belli infection in patients with the acquired immunodeficiency syndrome. N Engl J Med 315: 87–90, 1986.PubMedCrossRefGoogle Scholar
  221. 216.
    Scowden EB, Schaffner W, Stone WJ: Overwhelming strongyloidiasis: An unappreciated opportunistic infection. Medicine (Baltimore) 57: 527–544, 1978.Google Scholar
  222. 217.
    Rassiga AL, Lawry JL, Forman WB: Diffuse pulmonary infection due to strongyloides stercoalis. JAMA 230: 426–430, 1974.PubMedCrossRefGoogle Scholar
  223. 218.
    Scoggin CH, Call NB: Acute respiratory failure due to disseminated strongyloidiasis in a renal transplant recipient. Ann Intern Med 87: 456–458, 1977.PubMedGoogle Scholar
  224. 219.
    Kuberski TT, Gabor EP, Boudreaux D: Disseminated strongyloidiasis—A complication of the immunosuppressed host. West J Med 122: 504–508, 1975.PubMedGoogle Scholar
  225. 220.
    Rivera E, Maldonado N, Velez-Garcia E, et al: Hyperinfection with strongyloides stercoralis. Ann Intern Med 72: 199–204, 1970.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • Joel Ruskin
    • 1
    • 2
  1. 1.School of MedicineUniversity of California—Los AngelesLos AngelesUSA
  2. 2.Department of Medicine, Infectious Diseases ServiceKaiser Permanente Medical CenterLos AngelesUSA

Personalised recommendations